The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Artificial Cardiac Valves-Global Market Insights and Sales Trends 2024
Synopsis
The global Artificial Cardiac Valves market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Cardiac Valves in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centres and Others,, are propelling Artificial Cardiac Valves market. Mechanical Heart Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological/Tissue Heart Valves segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Artificial Cardiac Valves market, driven by demand from China, the second largest economy with some signs of stabilising, the Artificial Cardiac Valves market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Cardiac Valves, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Cardiac Valves market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Cardiac Valves market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Cardiac Valves sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Cardiac Valves covered in this report include Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, Abbott Laboratories, Symetis, LivaNova, CryoLife and Braile Biomedica, etc.
The global Artificial Cardiac Valves market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
Abbott
Medtronic
Edwards Lifesciences
Abbott Laboratories
Symetis
LivaNova
CryoLife
Braile Biomedica
Colibri Heart Valve
JenaValve Technology
Global Artificial Cardiac Valves market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Cardiac Valves market, Segment by Type:
Mechanical Heart Valves
Biological/Tissue Heart Valves
Transcatheter Heart Valves
Global Artificial Cardiac Valves market, by Application
Hospitals
Ambulatory Surgery Centres
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Cardiac Valves manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Cardiac Valves in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Artificial Cardiac Valves market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Artificial Cardiac Valves in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgery Centres and Others,, are propelling Artificial Cardiac Valves market. Mechanical Heart Valves, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biological/Tissue Heart Valves segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Artificial Cardiac Valves market, driven by demand from China, the second largest economy with some signs of stabilising, the Artificial Cardiac Valves market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Artificial Cardiac Valves, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Artificial Cardiac Valves market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Artificial Cardiac Valves market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Artificial Cardiac Valves sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Artificial Cardiac Valves covered in this report include Boston Scientific, Abbott, Medtronic, Edwards Lifesciences, Abbott Laboratories, Symetis, LivaNova, CryoLife and Braile Biomedica, etc.
The global Artificial Cardiac Valves market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
Abbott
Medtronic
Edwards Lifesciences
Abbott Laboratories
Symetis
LivaNova
CryoLife
Braile Biomedica
Colibri Heart Valve
JenaValve Technology
Global Artificial Cardiac Valves market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Artificial Cardiac Valves market, Segment by Type:
Mechanical Heart Valves
Biological/Tissue Heart Valves
Transcatheter Heart Valves
Global Artificial Cardiac Valves market, by Application
Hospitals
Ambulatory Surgery Centres
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Artificial Cardiac Valves manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Artificial Cardiac Valves in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Artificial Cardiac Valves Market Overview
1.1 Artificial Cardiac Valves Product Overview
1.2 Artificial Cardiac Valves Market Segment by Type
1.2.1 Mechanical Heart Valves
1.2.2 Biological/Tissue Heart Valves
1.2.3 Transcatheter Heart Valves
1.3 Global Artificial Cardiac Valves Market Size by Type
1.3.1 Global Artificial Cardiac Valves Market Size Overview by Type (2018-2029)
1.3.2 Global Artificial Cardiac Valves Historic Market Size Review by Type (2018-2023)
1.3.3 Global Artificial Cardiac Valves Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Artificial Cardiac Valves Sales Breakdown by Type (2018-2023)
1.4.2 Europe Artificial Cardiac Valves Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Artificial Cardiac Valves Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Artificial Cardiac Valves Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Artificial Cardiac Valves Sales Breakdown by Type (2018-2023)
2 Global Artificial Cardiac Valves Market Competition by Company
2.1 Global Top Players by Artificial Cardiac Valves Sales (2018-2023)
2.2 Global Top Players by Artificial Cardiac Valves Revenue (2018-2023)
2.3 Global Top Players by Artificial Cardiac Valves Price (2018-2023)
2.4 Global Top Manufacturers Artificial Cardiac Valves Manufacturing Base Distribution, Sales Area, Product Type
2.5 Artificial Cardiac Valves Market Competitive Situation and Trends
2.5.1 Artificial Cardiac Valves Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Artificial Cardiac Valves Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Cardiac Valves as of 2022)
2.7 Date of Key Manufacturers Enter into Artificial Cardiac Valves Market
2.8 Key Manufacturers Artificial Cardiac Valves Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Artificial Cardiac Valves Status and Outlook by Region
3.1 Global Artificial Cardiac Valves Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Artificial Cardiac Valves Historic Market Size by Region
3.2.1 Global Artificial Cardiac Valves Sales in Volume by Region (2018-2023)
3.2.2 Global Artificial Cardiac Valves Sales in Value by Region (2018-2023)
3.2.3 Global Artificial Cardiac Valves Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Artificial Cardiac Valves Forecasted Market Size by Region
3.3.1 Global Artificial Cardiac Valves Sales in Volume by Region (2024-2029)
3.3.2 Global Artificial Cardiac Valves Sales in Value by Region (2024-2029)
3.3.3 Global Artificial Cardiac Valves Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Artificial Cardiac Valves by Application
4.1 Artificial Cardiac Valves Market Segment by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgery Centres
4.1.3 Others
4.2 Global Artificial Cardiac Valves Market Size by Application
4.2.1 Global Artificial Cardiac Valves Market Size Overview by Application (2018-2029)
4.2.2 Global Artificial Cardiac Valves Historic Market Size Review by Application (2018-2023)
4.2.3 Global Artificial Cardiac Valves Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Artificial Cardiac Valves Sales Breakdown by Application (2018-2023)
4.3.2 Europe Artificial Cardiac Valves Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Artificial Cardiac Valves Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Artificial Cardiac Valves Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Artificial Cardiac Valves Sales Breakdown by Application (2018-2023)
5 North America Artificial Cardiac Valves by Country
5.1 North America Artificial Cardiac Valves Historic Market Size by Country
5.1.1 North America Artificial Cardiac Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Artificial Cardiac Valves Sales in Volume by Country (2018-2023)
5.1.3 North America Artificial Cardiac Valves Sales in Value by Country (2018-2023)
5.2 North America Artificial Cardiac Valves Forecasted Market Size by Country
5.2.1 North America Artificial Cardiac Valves Sales in Volume by Country (2024-2029)
5.2.2 North America Artificial Cardiac Valves Sales in Value by Country (2024-2029)
6 Europe Artificial Cardiac Valves by Country
6.1 Europe Artificial Cardiac Valves Historic Market Size by Country
6.1.1 Europe Artificial Cardiac Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Artificial Cardiac Valves Sales in Volume by Country (2018-2023)
6.1.3 Europe Artificial Cardiac Valves Sales in Value by Country (2018-2023)
6.2 Europe Artificial Cardiac Valves Forecasted Market Size by Country
6.2.1 Europe Artificial Cardiac Valves Sales in Volume by Country (2024-2029)
6.2.2 Europe Artificial Cardiac Valves Sales in Value by Country (2024-2029)
7 Asia-Pacific Artificial Cardiac Valves by Region
7.1 Asia-Pacific Artificial Cardiac Valves Historic Market Size by Region
7.1.1 Asia-Pacific Artificial Cardiac Valves Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Artificial Cardiac Valves Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Artificial Cardiac Valves Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Artificial Cardiac Valves Forecasted Market Size by Region
7.2.1 Asia-Pacific Artificial Cardiac Valves Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Artificial Cardiac Valves Sales in Value by Region (2024-2029)
8 Latin America Artificial Cardiac Valves by Country
8.1 Latin America Artificial Cardiac Valves Historic Market Size by Country
8.1.1 Latin America Artificial Cardiac Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Artificial Cardiac Valves Sales in Volume by Country (2018-2023)
8.1.3 Latin America Artificial Cardiac Valves Sales in Value by Country (2018-2023)
8.2 Latin America Artificial Cardiac Valves Forecasted Market Size by Country
8.2.1 Latin America Artificial Cardiac Valves Sales in Volume by Country (2024-2029)
8.2.2 Latin America Artificial Cardiac Valves Sales in Value by Country (2024-2029)
9 Middle East and Africa Artificial Cardiac Valves by Country
9.1 Middle East and Africa Artificial Cardiac Valves Historic Market Size by Country
9.1.1 Middle East and Africa Artificial Cardiac Valves Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Artificial Cardiac Valves Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Artificial Cardiac Valves Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Artificial Cardiac Valves Forecasted Market Size by Country
9.2.1 Middle East and Africa Artificial Cardiac Valves Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Artificial Cardiac Valves Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Boston Scientific
10.1.1 Boston Scientific Company Information
10.1.2 Boston Scientific Introduction and Business Overview
10.1.3 Boston Scientific Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Boston Scientific Artificial Cardiac Valves Products Offered
10.1.5 Boston Scientific Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Introduction and Business Overview
10.2.3 Abbott Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Artificial Cardiac Valves Products Offered
10.2.5 Abbott Recent Development
10.3 Medtronic
10.3.1 Medtronic Company Information
10.3.2 Medtronic Introduction and Business Overview
10.3.3 Medtronic Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medtronic Artificial Cardiac Valves Products Offered
10.3.5 Medtronic Recent Development
10.4 Edwards Lifesciences
10.4.1 Edwards Lifesciences Company Information
10.4.2 Edwards Lifesciences Introduction and Business Overview
10.4.3 Edwards Lifesciences Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Edwards Lifesciences Artificial Cardiac Valves Products Offered
10.4.5 Edwards Lifesciences Recent Development
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Company Information
10.5.2 Abbott Laboratories Introduction and Business Overview
10.5.3 Abbott Laboratories Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Laboratories Artificial Cardiac Valves Products Offered
10.5.5 Abbott Laboratories Recent Development
10.6 Symetis
10.6.1 Symetis Company Information
10.6.2 Symetis Introduction and Business Overview
10.6.3 Symetis Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Symetis Artificial Cardiac Valves Products Offered
10.6.5 Symetis Recent Development
10.7 LivaNova
10.7.1 LivaNova Company Information
10.7.2 LivaNova Introduction and Business Overview
10.7.3 LivaNova Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.7.4 LivaNova Artificial Cardiac Valves Products Offered
10.7.5 LivaNova Recent Development
10.8 CryoLife
10.8.1 CryoLife Company Information
10.8.2 CryoLife Introduction and Business Overview
10.8.3 CryoLife Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.8.4 CryoLife Artificial Cardiac Valves Products Offered
10.8.5 CryoLife Recent Development
10.9 Braile Biomedica
10.9.1 Braile Biomedica Company Information
10.9.2 Braile Biomedica Introduction and Business Overview
10.9.3 Braile Biomedica Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Braile Biomedica Artificial Cardiac Valves Products Offered
10.9.5 Braile Biomedica Recent Development
10.10 Colibri Heart Valve
10.10.1 Colibri Heart Valve Company Information
10.10.2 Colibri Heart Valve Introduction and Business Overview
10.10.3 Colibri Heart Valve Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Colibri Heart Valve Artificial Cardiac Valves Products Offered
10.10.5 Colibri Heart Valve Recent Development
10.11 JenaValve Technology
10.11.1 JenaValve Technology Company Information
10.11.2 JenaValve Technology Introduction and Business Overview
10.11.3 JenaValve Technology Artificial Cardiac Valves Sales, Revenue and Gross Margin (2018-2023)
10.11.4 JenaValve Technology Artificial Cardiac Valves Products Offered
10.11.5 JenaValve Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Artificial Cardiac Valves Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Artificial Cardiac Valves Industrial Chain Analysis
11.4 Artificial Cardiac Valves Market Dynamics
11.4.1 Artificial Cardiac Valves Industry Trends
11.4.2 Artificial Cardiac Valves Market Drivers
11.4.3 Artificial Cardiac Valves Market Challenges
11.4.4 Artificial Cardiac Valves Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Artificial Cardiac Valves Distributors
12.3 Artificial Cardiac Valves Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
